Abstract
Purpose
Many studies have found associations between laboratory biomarkers and periprosthetic joint infection (PJI), but it remains unclear whether these biomarkers are clinically useful in ruling out PJI. This meta-analysis compared the performance of interleukin-6 (IL-6) versus procalcitonin (PCT) for the diagnosis of PJI.
Methods
In this meta-analysis, we reviewed studies that evaluated IL-6 or/and PCT as a diagnostic biomarker for PJI and provided sufficient data to permit sensitivity and specificity analyses for each test. The major databases MEDLINE, EMBASE, the Cochrane Library, Web of Science, and SCOPUS were searched for appropriate studies from the earliest available date of indexing through February 28, 2017. No restrictions were placed on language of publication.
Results
We identified 18 studies encompassing a total of 1,835 subjects; 16 studies reported on IL-6 and 6 studies reported on PCT. The area under the curve (AUC) was 0.93 (95% CI, 0.91–0.95) for IL-6 and 0.83 (95% CI, 0.79–0.86) for PCT. The pooled sensitivity was 0.83 (95% CI, 0.74–0.89) for IL-6 and 0.58 (95% CI, 0.31–0.81) for PCT. The pooled specificity was 0.91 (95% CI, 0.84–0.95) for IL-6 and 0.95 (95% CI, 0.63–1.00) for PCT. Both the IL-6 and PCT tests had a high positive likelihood ratio (LR); 9.3 (95% CI, 5.3–16.2) and 12.4 (95% CI, 1.7–89.8), respectively, making them excellent rule-in tests for the diagnosis of PJI. The pooled negative LR for IL-6 was 0.19 (95% CI, 0.12–0.29), making it suitable as a rule-out test, whereas the pooled negative LR for PCT was 0.44 (95% CI, 0.25–0.78), making it unsuitable as a rule-out diagnostic tool.
Conclusions
Based on the results of the present meta-analysis, IL-6 has higher diagnostic value than PCT for the diagnosis of PJI. Moreover, the specificity of the IL-6 test is higher than its sensitivity. Conversely, PCT is not recommended for use as a rule-out diagnostic tool.
Similar content being viewed by others
References
Matar WY, Jafari SM, Restrepo C et al (2010) Preventing infection in total joint arthroplasty. J Bone Joint Surg Am 92(Suppl 2):36–46
Lenski M, Scherer MA (2014) Synovial IL-6 as inflammatory marker in periprosthetic joint infections. J Arthroplast 29(6):1105–1109
Parvizi J, Ghanem E, Menashe S et al (2006) Periprosthetic infection: what are the diagnostic challenges? J Bone Joint Surg Am 88(suppl 4):138–147
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351(16):1645–1654
Austin MS, Ghanem E, Joshi A et al (2008) A simple, cost-effective screening protocol to rule out periprosthetic infection. J Arthroplast 23(1):65–68
Ghanem E, Antoci V, Pulido L et al (2009) The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty. Int J Infect Dis 13(6):e444–e449
Deirmengian C, Hallab N, Tarabishy A et al (2010) Synovial fluid biomarkers for periprosthetic infection. Clin Orthop Relat Res 468(8):2017–2023
Parvizi J, Fassihi SC, Enayatollahi MA (2016) Diagnosis of periprosthetic joint infection following hip and knee Arthroplasty. Orthop Clin N Am 47(3):505–515
Parvizi J, Cavanaugh PK, Diaz-Ledezma C (2013) Periprosthetic knee infection: ten strategies that work. Knee Surg Relat Res 25(4):155–164
Di Cesare PE, Chang E, Preston CF et al (2005) Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg Am 87(9):1921–1927
Maharajan K, Patro DK, Menon J et al (2013) Serum procalcitonin is a sensitive and specific marker in the diagnosis of septic arthritis and acute osteomyelitis. J Orthop Surg Res 8(1):19
Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529–536
Deeks JJ (2001) Systematic reviews in health care: systematic reviews of evaluations of diagnostic and screening tests. BMJ 323(7305):157–162
Glas AS, Lijmer JG, Prins MH et al (2003) The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 56(11):1129–1135
Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58(9):882–893
Jacovides CL, Parvizi J, Adeli B et al (2011) Molecular markers for diagnosis of periprosthetic joint infection. J Arthroplast 26(Suppl 6):99–103
Abou El-Khier NT, El Ganainy AR, Elgeidy A et al (2013) Assessment of interleukin-6 and other inflammatory markers in the diagnosis of Egyptian patients with periprosthetic joint infection. Egypt J Immunol 20(2):93–99
Gollwitzer H, Dombrowski Y, Prodinger PM et al (2013) Antimicrobial peptides and proinflammatory cytokines in periprosthetic joint infection. J Bone Joint Surg Am 95(7):644–651
Elgeidi A, Elganainy AE, Abou Elkhier N et al (2014) Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection. Int Orthop 38(12):2591–2595
Bottner F, Wegner A, Winkelmann W et al (2007) Interleukin-6, procalcitonin and TNF-alpha: markers of peri-prosthetic infection following total joint replacement. J Bone Joint Surg Br 89(1):94–99
Deirmengian C, Kardos K, Kilmartin P et al (2014) Diagnosing periprosthetic joint infection: has the era of the biomarker arrived? Clin Orthop Relat Res 472(11):3254–3262
Glehr M, Friesenbichler J, Hofmann G et al (2013) Novel biomarkers to detect infection in revision hip and knee arthroplasties. Clin Orthop Relat Res 471(8):2621–2628
Worthington T, Dunlop D, Casey A et al (2010) Serum procalcitonin, interleukin-6, soluble intercellular adhesin molecule-1 and IgG to shortchain exocellular lipoteichoic acid as predictors of infection in total joint prosthesis revision. Br J Biomed Sci 67(2):71–76
Frangiamore SJ, Siqueira MB, Saleh A et al (2016) Synovial cytokines and the MSIS criteria are not useful for determining infection resolution after periprosthetic joint infection explantation. Clin Orthop Relat Res 474(7):1630–1639
Ettinger M, Calliess T, Kielstein JT et al (2015) Circulating biomarkers for discrimination between aseptic joint failure, low-grade infection and high-grade septic failure. Clin Infect Dis 61:332–341
Randau TM, Friedrich MJ, Wimmer MD et al (2014) Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening. PloS One 9(2):e89045
Tang X, Wang Q, Wang H et al (2016) [Comparison and estimation of different diagnostic methods in detecting the presence of periprosthetic joint infection]. Zhonghua Wai Ke Za Zhi 54(4):251–257
Yuan K, Li W-D, Qiang Y et al (2015) Comparison of procalcitonin and C-reactive protein for the diagnosis of periprosthetic joint infection before revision total hip arthroplasty. Surg Infect 16(2):146–150
Saeed K, Dryden M, Sitjar A et al (2013) Measuring synovial fluid procalcitonin levels in distinguishing cases of septic arthritis, including prosthetic joints, from other causes of arthritis and aseptic loosening. Infection 41(4):845–849
Nilsdotter-Augustinsson A, Briheim G, Herder A et al (2007) Inflammatory response in 85 patients with loosened hip prostheses: a prospective study comparing inflammatory markers in patients with aseptic and septic prosthetic loosening. Acta Orthop 78(5):629–639
Wirtz DC, Heller KD, Miltner O et al (2000) Interleukin-6: a potential inflammatory marker after total joint replacement. Int Orthop 24(4):194–196
Waddell J, Pritzker KP, Boynton EL (2005) Increased cytokine secretion in patients with failed implants compared with patients with primary implants. Clin Orthop Relat Res 434(434):170–176
Ahmad SS, Shaker A, Saffarini M et al (2016) Accuracy of diagnostic tests for prosthetic joint infection: a systematic review. Knee Surg Sports Traumatol Arthrosc 24(10):3064–3074
Parvizi J, Zmistowski B, Berbari EF et al (2011) New definition for periprosthetic joint infection: from the workgroup of the musculoskeletal infection society. Clin Orthop Relat Res 469(11):2992–2994
Fischer JE, Bachmann LM, Jaeschke R (2003) A readers’ guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med 29(7):1043–1051
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have to no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
There are no conflicts of interest between any of the contributors to this manuscript.
Additional information
Research of this study was performed at Veterans Health Service Medical Center.
Rights and permissions
About this article
Cite this article
Yoon, JR., Yang, SH. & Shin, YS. Diagnostic accuracy of interleukin-6 and procalcitonin in patients with periprosthetic joint infection: a systematic review and meta-analysis. International Orthopaedics (SICOT) 42, 1213–1226 (2018). https://doi.org/10.1007/s00264-017-3744-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00264-017-3744-3